Od-030588 MWHC Tenecteplase in Acute Stroke Management
Enroll
Type
On Demand
Credit
No
Description
This course cover the description, mixing, dosin, administration and complications/side effects related ... show more
Objectives
- Explain the difference between recombinant tissue plasminogen activator (tPA) and Tenecteplase
- Explain current literature for the use of Tenecteplase in the setting of acute ischemic stroke
- Identify how to reconstitute, calculate the dosage based on the patient weight and administer the Tenecteplase bolus
Fees
Free
Activity Director
Karen Poole
Karen.Moriarty@medstar.net
Organization
MedStar Health Research Institute